Literature DB >> 25421282

Reply: Heterogeneity of intermediate-stage HCC necessitates personalized management including surgery.

Alejandro Forner1, Marine Gilabert2, Jordi Bruix1, Jean-Luc Raoul2.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25421282     DOI： 10.1038/nrclinonc.2014.122-c2

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  15 in total

1.  Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

Authors:  Marta Burrel; María Reig; Alejandro Forner; Marta Barrufet; Carlos Rodríguez de Lope; Silvia Tremosini; Carmen Ayuso; Josep M Llovet; María Isabel Real; Jordi Bruix
Journal:  J Hepatol       Date:  2012-02-05       Impact factor: 25.083

2.  Heterogeneity of intermediate-stage HCC necessitates personalized management including surgery.

Authors:  Qiang Gao; Xiao-Ying Wang; Jian Zhou; Jia Fan
Journal:  Nat Rev Clin Oncol       Date:  2014-11-25       Impact factor: 66.675

3.  Staging for hepatocellular carcinoma: complex and confusing.

Authors:  Morris Sherman
Journal:  Gastroenterology       Date:  2014-04-26       Impact factor: 22.682

4.  Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis.

Authors:  Katerina Malagari; Mary Pomoni; Hippocrates Moschouris; Evanthia Bouma; John Koskinas; Aspasia Stefaniotou; Athanasios Marinis; Alexios Kelekis; Efthymia Alexopoulou; Achilles Chatziioannou; Katerina Chatzimichael; Spyridon Dourakis; Nikolaos Kelekis; Spyros Rizos; Dimitrios Kelekis
Journal:  Cardiovasc Intervent Radiol       Date:  2012-05-22       Impact factor: 2.740

5.  Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.

Authors:  Kenichi Takayasu; Shigeki Arii; Masatoshi Kudo; Takafumi Ichida; Osamu Matsui; Namiki Izumi; Yutaka Matsuyama; Michiie Sakamoto; Osamu Nakashima; Yonson Ku; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  J Hepatol       Date:  2011-12-13       Impact factor: 25.083

Review 6.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

7.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

Review 8.  Treatment of intermediate-stage hepatocellular carcinoma.

Authors:  Alejandro Forner; Marine Gilabert; Jordi Bruix; Jean-Luc Raoul
Journal:  Nat Rev Clin Oncol       Date:  2014-08-05       Impact factor: 66.675

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

10.  Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Authors:  Johannes Lammer; Katarina Malagari; Thomas Vogl; Frank Pilleul; Alban Denys; Anthony Watkinson; Michael Pitton; Geraldine Sergent; Thomas Pfammatter; Sylvain Terraz; Yves Benhamou; Yves Avajon; Thomas Gruenberger; Maria Pomoni; Herbert Langenberger; Marcus Schuchmann; Jerome Dumortier; Christian Mueller; Patrick Chevallier; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740
View more
  10 in total

1.  Intermediate-stage HCC--upfront resection can be feasible.

Authors:  Alejandro Forner; Marine Gilabert; Jordi Bruix; Jean-Luc Raoul
Journal:  Nat Rev Clin Oncol       Date:  2015-04-07       Impact factor: 66.675

Review 2.  BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.

Authors:  Maria Reig; Alejandro Forner; Jordi Rimola; Joana Ferrer-Fàbrega; Marta Burrel; Ángeles Garcia-Criado; Robin K Kelley; Peter R Galle; Vincenzo Mazzaferro; Riad Salem; Bruno Sangro; Amit G Singal; Arndt Vogel; Josep Fuster; Carmen Ayuso; Jordi Bruix
Journal:  J Hepatol       Date:  2021-11-19       Impact factor: 30.083

3.  Up-regulated expression of phospholipase C, β1 is associated with tumor cell proliferation and poor prognosis in hepatocellular carcinoma.

Authors:  Junxiang Li; Xuya Zhao; Dazhi Wang; Wei He; Shuai Zhang; Wei Cao; Yu Huang; Ling Wang; Shi Zhou; Kaijian Luo
Journal:  Onco Targets Ther       Date:  2016-03-21       Impact factor: 4.147

Review 4.  Controversies and evidence of hepatic resection for hepatocellular carcinoma.

Authors:  Jian-Hong Zhong; Guido Torzilli; Hao Xing; Chao Li; Jun Han; Lei Liang; Han Zhang; Shu-Yang Dai; Le-Qun Li; Feng Shen; Tian Yang
Journal:  BBA Clin       Date:  2016-10-11

5.  Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms.

Authors:  Young-Sun Lee; Yeon Seok Seo; Ji Hoon Kim; Juneyoung Lee; Hae Rim Kim; Yang Jae Yoo; Tae Suk Kim; Seong Hee Kang; Sang Jun Suh; Moon Kyung Joo; Young Kul Jung; Beom Jae Lee; Hyung Joon Yim; Jong Eun Yeon; Jae Seon Kim; Jong-Jae Park; Soon Ho Um; Young-Tae Bak; Kwan Soo Byun
Journal:  Gut Liver       Date:  2018-01-15       Impact factor: 4.519

6.  Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models.

Authors:  Yong-Fa Zhang; Ming Shi; Liang-He Lu; Lu Wang; Rong-Ping Guo
Journal:  J Hepatocell Carcinoma       Date:  2021-04-19

Review 7.  New concepts in the treatment of hepatocellular carcinoma.

Authors:  Sabrina Sidali; Eric Trépo; Olivier Sutter; Jean-Charles Nault
Journal:  United European Gastroenterol J       Date:  2022-08-16       Impact factor: 6.866

8.  Comparison of Partial Hepatectomy and Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Ismail Labgaa; Patrick Taffé; David Martin; Daniel Clerc; Myron Schwartz; Norihiro Kokudo; Alban Denys; Nermin Halkic; Nicolas Demartines; Emmanuel Melloul
Journal:  Liver Cancer       Date:  2020-01-28       Impact factor: 11.740

9.  TOP2A promotes proliferation and metastasis of hepatocellular carcinoma regulated by miR-144-3p.

Authors:  Tao Wang; Jing Lu; Rangrang Wang; Wanyue Cao; Junming Xu
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

10.  Corona Enhancement and Mosaic Architecture for Prognosis and Selection Between of Liver Resection Versus Transcatheter Arterial Chemoembolization in Single Hepatocellular Carcinomas >5 cm Without Extrahepatic Metastases: An Imaging-Based Retrospective Study.

Authors:  Meng Li; Yongjie Xin; Sirui Fu; Zaiyi Liu; Yong Li; Baoshan Hu; Shuting Chen; Changhong Liang; Ligong Lu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.